Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Talaris Therapeutics to Present at the 2022 Cell & Gene Meeting on the Mesa | ||
| By: GlobeNewswire - 04 Oct 2022 | Back to overview list |
|
BOSTON and LOUISVILLE, Ky., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will present at the 2022 Cell & Gene Meeting on the Mesa being held October 11-13, 2022 in Carlsbad, California and livestreamed globally. In addition, members from the management team will also be in attendance. A pre-recorded presentation will be available on-demand starting Tuesday, October 11, 2022. Please visit https://meetingonthemesa.com for full information including registration. About Talaris Therapeutics Media Contact Investor Contact 
|
||
|
||
 | Back to overview list | |